JANSSEN PHARMACEUTICA, INC. nka JANSSEN PHARMACEUTICALS, INC | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for JANSSEN PHARMACEUTICA, INC. nka JANSSEN PHARMACEUTICALS, INC

Sort by

Viewing results 1‒25 of 32

Johnson & Johnson Co Inc
Talcum powder cancer claims target J&J’s new consumer carve-out
...Janssen is the pharmaceutical division of J&J....
April 27, 2023
The Top LineTom Braithwaite
Why Pfizer has won the Covid vaccine race but isn’t getting credit
...Not only was the BioNTech/Pfizer vaccine the first to be deployed but it has suffered less from rare side effects and manufacturing glitches than its big western rivals Oxford/AstraZeneca, Janssen or Moderna...
October 15, 2021
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Covid-19 vaccines
J&J says Covid booster shot produced strong antibody response
...A booster shot of Johnson & Johnson’s Covid-19 vaccine produced a strong and rapid antibody response against the virus, the pharmaceutical company said on Wednesday....
August 25, 2021
Covid-19 vaccines
J&J seeks US authorisation for Covid-19 vaccine
FDA will now weigh whether to allow use of first single-dose jab to prevent the virus
February 4, 2021
Covid-19 vaccines
UK approves use of Johnson & Johnson vaccine
...“The Janssen vaccine will be another weapon in our arsenal to beat this pandemic,” said vaccines minister Nadhim Zahawi....
May 28, 2021
Covid-19 vaccines
FDA moves to authorise J&J’s Covid-19 vaccine
..., J&J’s pharmaceutical division, told the panel on Friday: “Janssen’s vaccine candidate would play a critical role in the global efforts to fight Covid-19 . . ....
February 27, 2021
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Johnson & Johnson Co Inc
Johnson & Johnson to buy biotech Momenta in $6.5bn deal
...The deal will give J&J’s drugmaking division Janssen Pharmaceutica access to Momenta’s pipeline of products, including nipocalimab, a promising treatment for the rare muscular disease myasthenia gravis that...
August 19, 2020
Covid-19 vaccines
J&J delays vaccine rollout in Europe after US health agencies call for pause
...“At present, no clear causal relationship has been established between these rare events and the Janssen [J&J] Covid-19 vaccine,” it said, adding that it was working closely with experts and regulators to...
April 13, 2021
Covid-19 vaccines
J&J vaccine shows 66% efficacy for moderate and severe Covid
...J&J is preparing to test a new formulation that could be targeted at the 501.v2 variant, but Mathai Mammen, global head of research and development for Janssen, J&J’s pharmaceuticals division, said he was...
January 29, 2021
Coronavirus treatment
J&J to launch UK trial of its Covid-19 vaccine
...Through its Janssen subsidiary, the New Jersey-based drugmaker will administer its experimental vaccine to 6,000 UK volunteers in two doses in a phase-3 trial....
November 16, 2020
News in-depthPharmaceuticals sector
Johnson & Johnson chief looks to the greater good
...He joined Janssen, J&J’s pharma division, in sales in 1988, with only a BA in biology....
April 3, 2020
Johnson & Johnson Co Inc
Johnson & Johnson faces court judgment over opioids crisis
...J&J — best known for consumer products such as “no more tears” baby shampoo — owns the Janssen pharmaceuticals business that sold two prescription opioids....
August 25, 2019
Pharmaceuticals sector
US approves first depression drug in decades
...Allergan, a Dublin-based pharmaceuticals company, is developing another antidepressant based on the glutamate system. It hopes to announce the results of its phase-3 clinical study on Rapastinel soon....
March 6, 2019
The Big ReadSarah Neville
Big pharma takes a gamble on NHS experiment
...Mr Rouse acknowledges that, Janssen’s enthusiasm aside, other companies have been less convinced of the advantages of outcomes-based pricing....
August 28, 2018
Brexit
Big pharma say Britain must continue to attract top scientists
...Two leading pharmaceutical companies have warned that the UK must continue to attract top scientific talent if it is to maintain its competitive edge....
December 6, 2017
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
US & Canadian companies
Johnson & Johnson unit speaks out at planned death row drug use
...Ms Foa added: “Pharmaceutical companies are clear that their drugs are for saving the lives of patients, not ending the lives of prisoners....
August 21, 2017
US & Canadian companies
Pfizer takes on J&J with antitrust lawsuit
...In a statement on Wednesday, Scott White, president at Janssen Biotech, a pharmaceuticals unit of J&J, said: “We are effectively competing on value and price and to date, Pfizer has failed to demonstrate...
September 20, 2017
Pharmaceuticals sector
Global health scares spur scientific innovation
...Johan Van Hoof, head of infectious diseases and vaccines at Janssen, part of the Johnson & Johnson pharmaceuticals group, says he also has cause for optimism....
April 24, 2016
Pharmaceuticals sector
Scientists make breakthrough in search for universal flu vaccine
...One team is a collaboration between the Scripps Research Institute in California and the Janssen Prevention Centre in the Netherlands, part of the Johnson and Johnson pharmaceutical group; the other is at...
August 24, 2015
US & Canadian companies
Sweeteners, incentives – and abundant water supplies – help draw multinationals to Wallonia
...A European distribution centre opened in 2012 by Janssen Pharmaceutica (part of the multinational Johnson & Johnson) met all of the criteria set by the regional government and received €11m out of a total...
November 5, 2014
Oil
Caterpillar falls on downgrade due to oil and gas exposure
...Shares of Isis Pharmaceuticals gained nearly 11 per cent to $69.19, after the company announced a collaboration with Janssen Biotech, a subsidiary of Johnson & Johnson, to develop drugs to treat autoimmune...
January 5, 2015
Pharmaceuticals sector
Digital future signals more active role for the patient
...Bill Hait, global head of research and development for Janssen, the pharmaceuticals arm of Johnson & Johnson, says the combination of big data and advances in genomic science is greatly increasing the potential...
December 10, 2014
Pharmaceuticals sector
Signs of a revival in drug development
...Average R&D intensity — the percentage of revenue invested in R&D — among drugmakers is almost 15 per cent, according to research by Deloitte, commissioned by Janssen, the pharmaceuticals arm of Johnson...
December 10, 2014
Sustainability
Green chemistry: Pharmaceutical companies try to clean up their act
...Addressing that issue is at the heart of Phil Dahlin’s role as director of sustainability for Janssen, the pharmaceuticals arm of Johnson & Johnson, the US consumer goods group....
June 29, 2014
EU economy
Tax deals raise questions over Ireland’s growth spurt
...Yet a chorus of economists say Irish official data have become so distorted this year by an upsurge in offshore activity from a small number of pharmaceutical companies that it paints a misleading picture...
December 9, 2014

Previous pagePage 1 of 2Next page